1
Orphan Designations
0 approved, 1 designated
0
FDA Approvals
0
Active Trials
7 recruiting
3
Rare Diseases
across 7 areas
0
News (30d)
Quiet
Richard I. Breuer, M.D. is a company with 1 orphan drug designation across 3 rare diseases.
Disease-by-disease pipeline progression from orphan designation through clinical trials to FDA approval.
Source: FDA Orphan Drug Designations, ClinicalTrials.gov, Drugs@FDA
| Disease | Drug(s) | Stage |
|---|---|---|
| chronic inflammatory demyelinating polyradiculoneuropathy | Short chain fatty acid enema | Des.TrialAppr. |
| chronic primary adrenal insufficiency | Short chain fatty acid enema | Des.TrialAppr. |
| de Sanctis-Cacchione syndrome | Short chain fatty acid enema | Des.TrialAppr. |
0% of portfolio targets high unmet need diseases
9
overlap in 2+ diseases
0/3
candidate diseases
0
avg importance: 0
0
affecting portfolio
0% of portfolio targets high unmet need diseases
9
overlap in 2+ diseases
0/3
candidate diseases
0
avg importance: 0
0
affecting portfolio